Biohaven Ltd. Share Price

Biohaven Ltd. Share Price

NYSE: BHVN | Small Cap
$15.43
-$1.02 (-6.23%) Last updated on 30 Oct, 2026 | 23:46 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Biohaven Ltd. Stock Performance

Open
$15.88
Prev. Close
$16.45
Circuit Range
N/A
Day Range
$15.13 - $16.18
Year Range
$7.50 - $18.53
Volume
1,12,693
Average Traded
$15.50

Biohaven Ltd. Share Price Today

As of 30 October 2026, Biohaven Ltd.'s share price is $15.43. The stock opened at $15.88, compared to its previous close of $16.45. During today's trading session, Biohaven Ltd.'s share price traded between $15.13 and $16.18, with an average price of $15.66. Over the past 52 weeks, the stock has recorded a high of $18.53 and a low of $7.50. In terms of performance, Biohaven Ltd.'s share price has risen by 60.90% over the last six months and is down 10.29% on a year-on-year basis.

Biohaven Ltd. Share Price Chart

Line chart of the Biohaven Ltd. price trend over the selected period. The price fell overall, ranging from 15.14 to 16.18, ending at 15.48.
$15.13$16.18
L
Show Current Price
H

Biohaven Ltd. Stock Fundamentals & Key Indicators

Market Cap
$1.66B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.89
Revenue (TTM)
$0.00
Return On Equity (TTM)
-4801.51%
Profit Margin
N/A
Debt to Equity
21.23
Quarterly Earnings Growth YoY
20.83%

Biohaven Ltd. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$173.44-$145.56-$130.53-$137.31
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A16.07%10.33%-5.19%

Biohaven Ltd. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$570.28-$408.17-$846.42-$738.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A28.43%-107.37%12.71%

About Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Biohaven Ltd. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$13.30
$15.48
+15.70%
Sep 2026
$15.28
$13.38
-17.00%
Aug 2026
$13.33
$16.12
+19.50%
Jul 2026
$15.09
$13.49
-9.25%
Jun 2026
$11.04
$14.87
+34.95%
May 2026
$9.70
$11.02
+14.86%
Apr 2026
$8.50
$9.59
+13.49%
Mar 2026
$11.34
$8.45
-26.65%
Feb 2026
$11.57
$11.52
-2.74%
Jan 2026
$11.37
$11.85
+5.01%
Dec 2025
$9.76
$11.28
+12.57%
Nov 2025
$14.90
$10.02
-41.74%

BHVN Share Price FAQs